Polyamine depletion therapy in prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-12

AUTHORS

BH Devens, RS Weeks, Burns, CL Carlson, MK Brawer

ABSTRACT

The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279 More... »

PAGES

4500420

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420

DOI

http://dx.doi.org/10.1038/sj.pcan.4500420

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011980478

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12497077


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devens", 
        "givenName": "BH", 
        "id": "sg:person.01026125710.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026125710.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weeks", 
        "givenName": "RS", 
        "id": "sg:person.011117074662.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011117074662.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burns", 
        "id": "sg:person.0644237665.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644237665.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlson", 
        "givenName": "CL", 
        "id": "sg:person.0576124465.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576124465.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwest Hospital and Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.416561.1", 
          "name": [
            "Northwest Prostate Institute, Northwest Hospital, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brawer", 
        "givenName": "MK", 
        "id": "sg:person.01026200644.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026200644.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3109/07853899109148056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021572844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-0-12-481835-4.50020-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028226153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-4347(00)83621-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044066151"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-12", 
    "datePublishedReg": "2000-12-01", 
    "description": "The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.pcan.4500420", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1119336", 
        "issn": [
          "1365-7852", 
          "1476-5608"
        ], 
        "name": "Prostate Cancer and Prostatic Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "name": "Polyamine depletion therapy in prostate cancer", 
    "pagination": "4500420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3914f5d1397b173913546fa24b0624fb960429964be54185eedb7c5ba94d1ab9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12497077"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9815755"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.pcan.4500420"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011980478"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.pcan.4500420", 
      "https://app.dimensions.ai/details/publication/pub.1011980478"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/4500420"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'


 

This table displays all metadata directly associated to this object as RDF triples.

113 TRIPLES      21 PREDICATES      32 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.pcan.4500420 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N6c0a6475108140a0930b83674d9d09c0
4 schema:citation https://doi.org/10.1016/b978-0-12-481835-4.50020-x
5 https://doi.org/10.1016/s0378-4347(00)83621-x
6 https://doi.org/10.3109/07853899109148056
7 schema:datePublished 2000-12
8 schema:datePublishedReg 2000-12-01
9 schema:description The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279
10 schema:genre research_article
11 schema:inLanguage en
12 schema:isAccessibleForFree true
13 schema:isPartOf N07408dd10f4f4457b89677f92069d396
14 Ne7f202a650e7425594a8f2ee3c8e01be
15 sg:journal.1119336
16 schema:name Polyamine depletion therapy in prostate cancer
17 schema:pagination 4500420
18 schema:productId N00eea02ba5734238bc2f3bb9e677437f
19 N1bdd007859cc4a1c973da2c612056e53
20 N3d8aeea1aaec48bbb61c2a46aa7dfb31
21 N4cb9deda98e24df1b5377ee6609e6094
22 N6a559b623ffa4b92b8454c0a8456dda7
23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011980478
24 https://doi.org/10.1038/sj.pcan.4500420
25 schema:sdDatePublished 2019-04-10T18:56
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher Na19e00270081454893273392efb6fc81
28 schema:url http://www.nature.com/articles/4500420
29 sgo:license sg:explorer/license/
30 sgo:sdDataset articles
31 rdf:type schema:ScholarlyArticle
32 N00eea02ba5734238bc2f3bb9e677437f schema:name doi
33 schema:value 10.1038/sj.pcan.4500420
34 rdf:type schema:PropertyValue
35 N07408dd10f4f4457b89677f92069d396 schema:volumeNumber 3
36 rdf:type schema:PublicationVolume
37 N1bdd007859cc4a1c973da2c612056e53 schema:name nlm_unique_id
38 schema:value 9815755
39 rdf:type schema:PropertyValue
40 N1fae7a067f8a4ce48bb02fbce2927c55 rdf:first sg:person.0576124465.60
41 rdf:rest Nbec0897f5bad41c689692227e4c4f393
42 N3c6b1a89fb4149c49b7db502218e4856 rdf:first sg:person.011117074662.90
43 rdf:rest Nc884bb5f8b084d169e267e16e29751b4
44 N3d8aeea1aaec48bbb61c2a46aa7dfb31 schema:name dimensions_id
45 schema:value pub.1011980478
46 rdf:type schema:PropertyValue
47 N4cb9deda98e24df1b5377ee6609e6094 schema:name pubmed_id
48 schema:value 12497077
49 rdf:type schema:PropertyValue
50 N6a559b623ffa4b92b8454c0a8456dda7 schema:name readcube_id
51 schema:value 3914f5d1397b173913546fa24b0624fb960429964be54185eedb7c5ba94d1ab9
52 rdf:type schema:PropertyValue
53 N6c0a6475108140a0930b83674d9d09c0 rdf:first sg:person.01026125710.11
54 rdf:rest N3c6b1a89fb4149c49b7db502218e4856
55 N9b27af88a93f44b4aa4b244bd9a53dfb schema:name Oridigm Corporation, Seattle, WA, USA
56 rdf:type schema:Organization
57 Na19e00270081454893273392efb6fc81 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 Na8b2d13a84124e379eb2ad14e3f23bb4 schema:name Oridigm Corporation, Seattle, WA, USA
60 rdf:type schema:Organization
61 Naafd245d6bb14ca28701fc1d7509662d schema:name Oridigm Corporation, Seattle, WA, USA
62 rdf:type schema:Organization
63 Naea8076e10a64859b30a0f959b68d878 schema:name Oridigm Corporation, Seattle, WA, USA
64 rdf:type schema:Organization
65 Nbec0897f5bad41c689692227e4c4f393 rdf:first sg:person.01026200644.85
66 rdf:rest rdf:nil
67 Nc884bb5f8b084d169e267e16e29751b4 rdf:first sg:person.0644237665.63
68 rdf:rest N1fae7a067f8a4ce48bb02fbce2927c55
69 Ne7f202a650e7425594a8f2ee3c8e01be schema:issueNumber 4
70 rdf:type schema:PublicationIssue
71 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
72 schema:name Medical and Health Sciences
73 rdf:type schema:DefinedTerm
74 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
75 schema:name Oncology and Carcinogenesis
76 rdf:type schema:DefinedTerm
77 sg:journal.1119336 schema:issn 1365-7852
78 1476-5608
79 schema:name Prostate Cancer and Prostatic Diseases
80 rdf:type schema:Periodical
81 sg:person.01026125710.11 schema:affiliation Na8b2d13a84124e379eb2ad14e3f23bb4
82 schema:familyName Devens
83 schema:givenName BH
84 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026125710.11
85 rdf:type schema:Person
86 sg:person.01026200644.85 schema:affiliation https://www.grid.ac/institutes/grid.416561.1
87 schema:familyName Brawer
88 schema:givenName MK
89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026200644.85
90 rdf:type schema:Person
91 sg:person.011117074662.90 schema:affiliation N9b27af88a93f44b4aa4b244bd9a53dfb
92 schema:familyName Weeks
93 schema:givenName RS
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011117074662.90
95 rdf:type schema:Person
96 sg:person.0576124465.60 schema:affiliation Naafd245d6bb14ca28701fc1d7509662d
97 schema:familyName Carlson
98 schema:givenName CL
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576124465.60
100 rdf:type schema:Person
101 sg:person.0644237665.63 schema:affiliation Naea8076e10a64859b30a0f959b68d878
102 schema:familyName Burns
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644237665.63
104 rdf:type schema:Person
105 https://doi.org/10.1016/b978-0-12-481835-4.50020-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028226153
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1016/s0378-4347(00)83621-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044066151
108 rdf:type schema:CreativeWork
109 https://doi.org/10.3109/07853899109148056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021572844
110 rdf:type schema:CreativeWork
111 https://www.grid.ac/institutes/grid.416561.1 schema:alternateName Northwest Hospital and Medical Center
112 schema:name Northwest Prostate Institute, Northwest Hospital, Seattle, WA, USA
113 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...